Natural antibodies bridge innate and adaptive immunity

Journal of Immunology

Volumn 194, Issue 1, 2015, Pages 13-20

  Panda, Saswati ^b   Ding, Jeak L ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FICOLIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; LECTIN; IMMUNOGLOBULIN G;

ACCURACY; ADAPTIVE IMMUNITY; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD LEVEL; CELL ASSAY; CELL FUNCTION; CELL SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; IMMUNOLOGY; INFECTION; INFLAMMATION; MOUSE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFECTION; INFLAMMATION; LECTINS; MICE;

EID: 84919624844     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400844     Document Type: Review

References (126)

1. Burton, D. R., and J. M. Woof. 1992. Human antibody effector function. Adv. Immunol. 51: 1-84.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
3. Zitvogel, L. 2002. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 195: F9-F14.
4. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
5. Dempsey, P. W., S. A. Vaidya, and G. Cheng. 2003. The art of war: Innate and adaptive immune responses. Cell. Mol. Life Sci. 60: 2604-2621.
6. Jacob, J., G. Kelsoe, K. Rajewsky, and U. Weiss. 1991. Intraclonal generation of antibody mutants in germinal centres. Nature 354: 389-392.
7. Berek, C., A. Berger, and M. Apel. 1991. Maturation of the immune response in germinal centers. Cell 67: 1121-1129.
8. Tarlinton, D. M., and K. G. Smith. 2000. Dissecting affinity maturation: A model explaining selection of antibody-forming cells and memory B cells in the germinal centre. Immunol. Today 21: 436-441.
9. Stavnezer, J., J. E. Guikema, and C. E. Schrader. 2008. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26: 261-292.
10. Fellah, J. S., M. V. Wiles, J. Charlemagne, and J. Schwager. 1992. Evolution of vertebrate IgM: Complete amino acid sequence of the constant region of Ambystoma mexicanum mu chain deduced from cDNA sequence. Eur. J. Immunol. 22: 2595-2601.
11. Boes, M. 2000. Role of natural and immune IgM antibodies in immune responses. Mol. Immunol. 37: 1141-1149.
12. Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
13. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
14. Schur, P. H. 1987. IgG subclasses-A review. Ann. Allergy 58: 89-96, 99.
15. Woof, J. M., and M. A. Kerr. 2006. The function of immunoglobulin A in immunity. J. Pathol. 208: 270-282.
16. Underdown, B. J., and J. M. Schiff. 1986. Immunoglobulin A: Strategic defense initiative at the mucosal surface. Annu. Rev. Immunol. 4: 389-417.
17. Yan, H., M. E. Lamm, E. Björling, and Y. T. Huang. 2002. Multiple functions of immunoglobulin A in mucosal defense against viruses: An in vitro measles virus model. J. Virol. 76: 10972-10979.
18. Chen, K., W. Xu, M. Wilson, B. He, N. W. Miller, E. Bengtén, E. S. Edholm, P. A. Santini, P. Rath, A. Chiu, et al. 2009. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat. Immunol. 10: 889-898.
19. Chen, K., and A. Cerutti. 2010. New insights into the enigma of immunoglobulin D. Immunol. Rev. 237: 160-179.
20. Carroll, M. C., and M. B. Fischer. 1997. Complement and the immune response. Curr. Opin. Immunol. 9: 64-69.
21. Carroll, M. C. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16: 545-568.
22. Boross, P., and J. H. Leusen. 2012. Boosting antibody therapy with complement. Blood 119: 5945-5947.
23. Haigwood, N. L., and L. Stamatatos. 2003. Role of neutralizing antibodies in HIV infection. AIDS 17(Suppl. 4): S67-S71.
24. Corti, D., and A. Lanzavecchia. 2013. Broadly neutralizing antiviral antibodies. Annu. Rev. Immunol. 31: 705-742.
25. Sutterwala, F. S., G. J. Noel, P. Salgame, and D. M. Mosser. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J. Exp. Med. 188: 217-222.
26. Kurosaka, K., N. Watanabe, and Y. Kobayashi. 2002. Potentiation by human serum of anti-inflammatory cytokine production by human macrophages in response to apoptotic cells. J. Leukoc. Biol. 71: 950-956.
27. Hart, S. P., C. Jackson, L. M. Kremmel, M. S. McNeill, H. Jersmann, K. M. Alexander, J. A. Ross, and I. Dransfield. 2003. Specific binding of an antigen-Antibody complex to apoptotic human neutrophils. Am. J. Pathol. 162: 1011-1018.
28. Mota, G., M. Manciulea, E. Cosma, I. Popescu, M. Hirt, E. Jensen-Jarolim, A. Calugaru, C. Galatiuc, T. Regalia, D. Tamandl, et al. 2003. Human NK cells express Fc receptors for IgA which mediate signal transduction and target cell killing. Eur. J. Immunol. 33: 2197-2205.
29. Perussia, B. 1998. Fc receptors on natural killer cells. Curr. Top. Microbiol. Immunol. 230: 63-88.
30. Avrameas, S. 1991. Natural autoantibodies: From 'horror autotoxicus' to 'gnothi seauton'. Immunol. Today 12: 154-159.
31. Coutinho, A., M. D. Kazatchkine, and S. Avrameas. 1995. Natural autoantibodies. Curr. Opin. Immunol. 7: 812-818.
32. Kantor, A. B., and L. A. Herzenberg. 1993. Origin of murine B cell lineages. Annu. Rev. Immunol. 11: 501-538.
33. Hardy, R. R., and K. Hayakawa. 1994. CD5 B cells, a fetal B cell lineage. Adv. Immunol. 55: 297-339.
34. Hardy, R. R., C. E. Carmack, Y. S. Li, and K. Hayakawa. 1994. Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol. Rev. 137: 91-118.
35. Conrad, K., M. P. Bachmann, E. Matsuura, and Y. Shoenfeld. 2005. From animal models to human genetics: Research on the induction and pathogenicity of autoantibodies. Autoimmun. Rev. 4: 178-187.
36. Harindranath, N., H. Ikematsu, A. L. Notkins, and P. Casali. 1993. Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase. Int. Immunol. 5: 1523-1533.
37. Schettino, E. W., S. K. Chai, M. T. Kasaian, H. W. Schroeder, Jr., and P. Casali. 1997. VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: Evidence for somatic selection. J. Immunol. 158: 2477-2489.
38. Kearney, J. F. 2000. Immune recognition of OxLDL in atherosclerosis. J. Clin. Invest. 105: 1683-1685.
39. Shaw, P. X., S. Hörkkö, M. K. Chang, L. K. Curtiss, W. Palinski, G. J. Silverman, and J. L. Witztum. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105: 1731-1740.
40. Ehrenstein, M. R., and C. A. Notley. 2010. The importance of natural IgM: Scavenger, protector and regulator. Nat. Rev. Immunol. 10: 778-786.
41. Baumgarth, N., O. C. Herman, G. C. Jager, L. Brown, L. A. Herzenberg, and L. A. Herzenberg. 1999. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA 96: 2250-2255.
42. Casali, P., and E. W. Schettino. 1996. Structure and function of natural antibodies. Curr. Top. Microbiol. Immunol. 210: 167-179.
43. Sidman, C. L., L. D. Shultz, R. R. Hardy, K. Hayakawa, and L. A. Herzenberg. 1986. Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. Science 232: 1423-1425.
44. Bos, N. A., H. Kimura, C. G. Meeuwsen, H. De Visser, M. P. Hazenberg, B. S. Wostmann, J. R. Pleasants, R. Benner, and D. M. Marcus. 1989. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur. J. Immunol. 19: 2335-2339.
45. Haury, M., A. Sundblad, A. Grandien, C. Barreau, A. Coutinho, and A. Nobrega. 1997. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur. J. Immunol. 27: 1557-1563.
46. Hooijkaas, H., R. Benner, J. R. Pleasants, and B. S. Wostmann. 1984. Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered "antigen-free" diet. Eur. J. Immunol. 14: 1127-1130.
47. Okech, B. A., A. Nalunkuma, D. Okello, X. L. Pang, K. Suzue, J. Li, T. Horii, and T. G. Egwang. 2001. Natural human immunoglobulin G subclass responses to Plasmodium falciparum serine repeat antigen in Uganda. Am. J. Trop. Med. Hyg. 65: 912-917.
48. Berland, R., and H. H.Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
49. Hirose, S., M. Wakiya, Y. Kawano-Nishi, J. Yi, R. Sanokawa, S. Taki, T. Shimamura, T. Kishimoto, H. Tsurui, H. Nishimura, et al. 1993. Somatic diversification and affinity maturation of IgM and IgG anti-DNA antibodies in murine lupus. Eur. J. Immunol. 23: 2813-2820.
50. Kantor, A. B., A. M. Stall, S. Adams, K. Watanabe, and L. A. Herzenberg. 1995. De novo development and self-replenishment of B cells. Int. Immunol. 7: 55-68.
51. Gioud, M., B. L. Kotzin, R. L. Rubin, F. G. Joslin, and E. M. Tan. 1983. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice. J. Immunol. 131: 269-274.
52. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
53. Lalor, P. A., L. A. Herzenberg, S. Adams, and A. M. Stall. 1989. Feedback regulation of murine Ly-1 B cell development. Eur. J. Immunol. 19: 507-513.
54. Deenen, G. J., and F. G. Kroese. 1992. Murine peritoneal Ly-1 B cells do not turn over rapidly. Ann. N. Y. Acad. Sci. 651: 70-71.
55. Duber, S., M. Hafner, M. Krey, S. Lienenklaus, B. Roy, E. Hobeika, M. Reth, T. Buch, A. Waisman, K. Kretschmer, and S. Weiss. 2009. Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood 114: 4960-4967.
56. Holodick, N. E., K. Repetny, X. Zhong, and T. L. Rothstein. 2009. Adult BM generates CD5+ B1 cells containing abundant N-region additions. Eur. J. Immunol. 39: 2383-2394.
57. Griffin, D. O., N. E. Holodick, and T. L. Rothstein. 2011. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD702. J. Exp. Med. 208: 67-80.
58. Kasaian, M. T., H. Ikematsu, J. E. Balow, and P. Casali. 1994. Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus. J. Immunol. 152: 3137-3151.
59. Harindranath, N., I. S. Goldfarb, H. Ikematsu, S. E. Burastero, R. L. Wilder, A. L. Notkins, and P. Casali. 1991. Complete sequence of the genes encoding the VH and VL regions of low- and high-Affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient. Int. Immunol. 3: 865-875.
60. Cerutti, A., M. Cols, and I. Puga. 2013. Marginal zone B cells: Virtues of innatelike antibody-producing lymphocytes. Nat. Rev. Immunol. 13: 118-132.
61. Capolunghi, F., S. Cascioli, E. Giorda, M. M. Rosado, A. Plebani, C. Auriti, G. Seganti, R. Zuntini, S. Ferrari, M. Cagliuso, et al. 2008. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J. Immunol. 180: 800-808.
62. Descatoire, M., J. C. Weill, C. A. Reynaud, and S. Weller. 2011. A human equivalent of mouse B-1 cells? J. Exp. Med. 208: 2563-2564.
63. Ohdan, H., K. G. Swenson, H. S. Kruger Gray, Y. G. Yang, Y. Xu, A. D. Thall, and M. Sykes. 2000. Mac-1-negative B-1b phenotype of natural antibodyproducing cells, including those responding to Gal alpha 1, 3Gal epitopes in alpha 1, 3-galactosyltransferase-deficient mice. J. Immunol. 165: 5518-5529.
64. Parker, W., S. S. Lin, P. B. Yu, A. Sood, Y. C. Nakamura, A. Song, M. L. Everett, and J. L. Platt. 1999. Naturally occurring anti-Alpha-galactosyl antibodies: Relationship to xenoreactive anti-Alpha-galactosyl antibodies. Glycobiology 9: 865-873.
65. Parker, W., K. Lundberg-Swanson, Z. E. Holzknecht, J. Lateef, S. A. Washburn, S. J. Braedehoeft, and J. L. Platt. 1996. Isohemagglutinins and xenoreactive antibodies: Members of a distinct family of natural antibodies. Hum. Immunol. 45: 94-104.
66. Baumgarth, N., J. W. Tung, and L. A. Herzenberg. 2005. Inherent specificities in natural antibodies: A key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 26: 347-362.
67. Choi, Y. S., J. A. Dieter, K. Rothaeusler, Z. Luo, and N. Baumgarth. 2012. B-1 cells in the bone marrow are a significant source of natural IgM. Eur. J. Immunol. 42: 120-129.
68. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2: 323-335.
69. Kretschmer, K., A. Jungebloud, J. Stopkowicz, T. Kleinke, R. Hoffmann, and S. Weiss. 2003. The selection of marginal zone B cells differs from that of B-1a cells. J. Immunol. 171: 6495-6501.
70. Carey, J. B., C. S. Moffatt-Blue, L. C. Watson, A. L. Gavin, and A. J. Feeney. 2008. Repertoire-based selection into the marginal zone compartment during B cell development. J. Exp. Med. 205: 2043-2052.
71. Dorshkind, K., and E. Montecino-Rodriguez. 2007. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat. Rev. Immunol. 7: 213-219.
72. Montecino-Rodriguez, E., H. Leathers, and K. Dorshkind. 2006. Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7: 293-301.
73. Montecino-Rodriguez, E., and K. Dorshkind. 2012. B-1 B cell development in the fetus and adult. Immunity 36: 13-21.
74. Czajkowsky, D. M., and Z. Shao. 2009. The human IgM pentamer is a mushroomshaped molecule with a flexural bias. Proc. Natl. Acad. Sci. USA 106: 14960-14965.
75. Bonagura, V. R., L. Mendez, N. Agostino, and B. Pernis. 1987. Monomeric (7S) IgM found in the serum of rheumatoid arthritis patients share idiotypes with pentameric (19S) monoclonal rheumatoid factors. J. Clin. Invest. 79: 813-818.
76. Fakunle, Y. M., F. Aranguibel, D. de Villiers, H. C. Thomas, and S. Sherlock. 1979. Monomeric (7S) IgM in chronic liver disease. Clin. Exp. Immunol. 38: 204-210.
77. Zhou, Z. H., Y. Zhang, Y. F. Hu, L. M. Wahl, J. O. Cisar, and A. L. Notkins. 2007. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1: 51-61.
78. Briles, D. E., M. Nahm, K. Schroer, J. Davie, P. Baker, J. Kearney, and R. Barletta. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 153: 694-705.
79. Subramaniam, K. S., K. Datta, E. Quintero, C. Manix, M. S. Marks, and L. A. Pirofski. 2010. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J. Immunol. 184: 5755-5767.
80. Ochsenbein, A. F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R. M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
81. Baumgarth, N., O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg, and J. Chen. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192: 271-280.
82. Choi, Y. S., and N. Baumgarth. 2008. Dual role for B-1a cells in immunity to influenza virus infection. J. Exp. Med. 205: 3053-3064.
83. Jayasekera, J. P., E. A. Moseman, and M. C. Carroll. 2007. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J. Virol. 81: 3487-3494.
84. Boes, M., A. P. Prodeus, T. Schmidt, M. C. Carroll, and J. Chen. 1998. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188: 2381-2386.
85. Ogden, C. A., R. Kowalewski, Y. Peng, V. Montenegro, and K. B. Elkon. 2005. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 38: 259-264.
86. Boes, M., C. Esau, M. B. Fischer, T. Schmidt, M. Carroll, and J. Chen. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160: 4776-4787.
87. Chen, Y., Y. B. Park, E. Patel, and G. J. Silverman. 2009. IgM antibodies to apoptosis-Associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol. 182: 6031-6043.
88. Notley, C. A., N. Baker, and M. R. Ehrenstein. 2010. Secreted IgM enhances B cell receptor signaling and promotes splenic but impairs peritoneal B cell survival. J. Immunol. 184: 3386-3393.
89. Chen, Y., S. Khanna, C. S. Goodyear, Y. B. Park, E. Raz, S. Thiel, C. Grönwall, J. Vas, D. L. Boyle, M. Corr, et al. 2009. Regulation of dendritic cells and macrophages by an anti-Apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol. 183: 1346-1359.
90. Fabrizio, K., A. Groner, M. Boes, and L. A. Pirofski. 2007. A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection. Clin. Vaccine Immunol. 14: 382-390.
91. Lewis, M. J., T. H. Malik, M. R. Ehrenstein, J. J. Boyle, M. Botto, and D. O. Haskard. 2009. Immunoglobulin M is required for protection against atherosclerosis in lowdensity lipoprotein receptor-deficient mice. Circulation 120: 417-426.
92. Boes, M., T. Schmidt, K. Linkemann, B. C. Beaudette, A. Marshak-Rothstein, and J. Chen. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97: 1184-1189.
93. Ehrenstein, M. R., H. T. Cook, and M. S. Neuberger. 2000. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J. Exp. Med. 191: 1253-1258.
94. Quartier, P., P. K. Potter, M. R. Ehrenstein, M. J. Walport, and M. Botto. 2005. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur. J. Immunol. 35: 252-260.
95. Nauta, A. J., N. Raaschou-Jensen, A. Roos, M. R. Daha, H. O. Madsen, M. C. Borrias-Essers, L. P. Ryder, C. Koch, and P. Garred. 2003. Mannosebinding lectin engagement with late apoptotic and necrotic cells. Eur. J. Immunol. 33: 2853-2863.
96. Arnold, J. N., M. R. Wormald, D. M. Suter, C. M. Radcliffe, D. J. Harvey, R. A. Dwek, P. M. Rudd, and R. B. Sim. 2005. Human serum IgM glycosylation: Identification of glycoforms that can bind to mannan-binding lectin. J. Biol. Chem. 280: 29080-29087.
97. Boyden, S. V. 1966. Natural antibodies and the immune response. Adv. Immunol. 5: 1-28.
98. Panda, S., J. Zhang, N. S. Tan, B. Ho, and J. L. Ding. 2013. Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. EMBO J. 32: 2905-2919.
99. Craig, A., J. Mai, S. Cai, and S. Jeyaseelan. 2009. Neutrophil recruitment to the lungs during bacterial pneumonia. Infect. Immun. 77: 568-575.
100. Zhou, J., S. A. Stohlman, D. R. Hinton, and N. W. Marten. 2003. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J. Immunol. 170: 3331-3336.
101. Baranov, D., and P. Neligan. 2007. Trauma and aggressive homeostasis management. Anesthesiol. Clin. 25: 49-63, viii.
102. Simmen, H. P., H. Battaglia, P. Giovanoli, and J. Blaser. 1994. Analysis of pH, pO2 and pCO2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery. Infection 22: 386-389.
103. Bessman, A. N., J. Page, and L. J. Thomas. 1989. In vivo pH of induced soft-tissue abscesses in diabetic and nondiabetic mice. Diabetes 38: 659-662.
104. TranVan Nhieu, G., C. Clair, G. Grompone, and P. Sansonetti. 2004. Calcium signalling during cell interactions with bacterial pathogens. Biol. Cell 96: 93-101.
105. Prince, A. S., J. P. Mizgerd, J. Wiener-Kronish, and J. Bhattacharya. 2006. Cell signaling underlying the pathophysiology of pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L297-L300.
106. Eichstaedt, S., K. Gäbler, S. Below, C. Muller, C. Kohler, S. Engelmann, P. Hildebrandt, U. Völker, M. Hecker, and J. P. Hildebrandt. 2009. Effects of Staphylococcus aureus-hemolysin A on calcium signalling in immortalized human airway epithelial cells. Cell Calcium 45: 165-176.
107. Zhang, J., J. Koh, J. Lu, S. Thiel, B. S. Leong, S. Sethi, C. Y. He, B. Ho, and J. L. Ding. 2009. Local inflammation induces complement crosstalk which amplifies the antimicrobial response. PLoS Pathog. 5: E1000282.
108. Puga, I., and A. Cerutti. 2013. Protection by natural IgG: A sweet partnership with soluble lectins does the trick! EMBO J. 32: 2897-2899.
109. Panda, S., J. Zhang, L. Yang, G. S. Anand, and J. L. Ding. 2014. Molecular interaction between natural IgG and ficolin-mechanistic insights on adaptive-innate immune crosstalk. Sci. Rep. 4: 3675.
110. Medzhitov, R., and C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
111. Beutler, B., Z. Jiang, P. Georgel, K. Crozat, B. Croker, S. Rutschmann, X. Du, and K. Hoebe. 2006. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24: 353-389.
112. Brown, G. D. 2006. Dectin-1: A signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 6: 33-43.
113. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zähringer, and B. Beutler. 2005. CD36 is a sensor of diacylglycerides. Nature 433: 523-527.
114. McGrath, F. D., M. C. Brouwer, G. J. Arlaud, M. R. Daha, C. E. Hack, and A. Roos. 2006. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J. Immunol. 176: 2950-2957.
115. Lu, J., K. D. Marjon, C. Mold, T. W. Du Clos, and P. D. Sun. 2012. Pentraxins and Fc receptors. Immunol. Rev. 250: 230-238.
116. Mantovani, A., S. Valentino, S. Gentile, A. Inforzato, B. Bottazzi, and C. Garlanda. 2013. The long pentraxin PTX3: A paradigm for humoral pattern recognition molecules. Ann. N. Y. Acad. Sci. 1285: 1-14.
117. Duncan, A. R., and G. Winter. 1988. The binding site for C1q on IgG. Nature 332: 738-740.
118. Senaldi, G., R. Ireland, A. J. Bellingham, D. Vergani, K. Veerapan, and F. Wang. 1988. IgM reduction in systemic lupus erythematosus. Arthritis Rheum. 31: 1213.
119. Shaw, P. X., C. S. Goodyear, M. K. Chang, J. L. Witztum, and G. J. Silverman. 2003. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosisassociated neo-Antigens and apoptotic cells. J. Immunol. 170: 6151-6157.
120. Tuominen, A., Y. I. Miller, L. F. Hansen, Y. A. Kesäniemi, J. L. Witztum, and S. Hörkkö. 2006. A natural antibody to oxidized cardiolipin binds to oxidized lowdensity lipoprotein, apoptotic cells, and atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 26: 2096-2102.
121. Gray, M., K. Miles, D. Salter, D. Gray, and J. Savill. 2007. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl. Acad. Sci. USA 104: 14080-14085.
122. Kanevets, U., K. Sharma, K. Dresser, and Y. Shi. 2009. A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity. J. Immunol. 182: 1912-1918.
123. Kulik, L., S. D. Fleming, C. Moratz, J. W. Reuter, A. Novikov, K. Chen, K. A. Andrews, A. Markaryan, R. J. Quigg, G. J. Silverman, et al. 2009. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J. Immunol. 182: 5363-5373.
124. Haas, M. S., E. M. Alicot, F. Schuerpf, I. Chiu, J. Li, F. D. Moore, and M. C. Carroll. 2010. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc. Res. 87: 618-627.
125. Subramanian, K., R. Du, N. S. Tan, B. Ho, and J. L. Ding. 2013. CD163 and IgG codefend against cytotoxic hemoglobin via autocrine and paracrine mechanisms. J. Immunol. 190: 5267-5278.
126. Hess, C., A. Winkler, A. K. Lorenz, V. Holecska, V. Blanchard, S. Eiglmeier, A. L. Schoen, J. Bitterling, A. D. Stoehr, D. Petzold, et al. 2013. T cellindependent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 123: 3788-3796.